In addition to p53/p66shc signaling, we suggest that the miR-34a/SIRT1/p66shc-mediated proapoptotic pathway has a pivotal role in NAFLD. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatotic liver disease.